ArticleDementia and neurocognitive disorders2025
Clinical Utility and Diagnostic Accuracy of the Tablet-Based Seoul Cognitive Status Test: Evidence for Scalable Cognitive Assessment.
Article in Dementia and neurocognitive disorders, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Scenario-Based Serious Game for Screening Mild Cognitive Impairment in Older Adults: Cross-Sectional Preliminary Validation Study.JMIR serious games · 2026Article
- Demographic, Social, and Clinical Profiles of Patients Initiating Lecanemab in Clinical Practice: A Single-Center Experience in Korea.Dementia and neurocognitive disorders · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background and Purpose: The Seoul Cognitive Status Test (SCST) is a brief (~30 minutes), tablet-based battery that yields domain-specific and composite scores and uses automated scoring for rapid result generation, reduced examiner burden, and scalability for large or longitudinal assessments. We evaluated the SCST's psychometric and diagnostic performance against multidisciplinary final clinical diagnoses derived from a multidimensional workup. Methods: We conducted a cross-sectional diagnostic study of 777 outpatients (SCST-Seoul Neuropsychological Screening Battery [SNSB] n=639; SCST-Consortium to Establish a Registry for Alzheimer's Disease [CERAD] n=138) who underwent standardized diagnostic evaluation; multidisciplinary final diagnoses served as the reference. Participants completed the SCST and either the Korean version of CERAD (CERAD-K) or SNSB-second edition (SNSB-II). We assessed convergent validity of SCST subtests with traditional measures and compared SCST composite scores and classifications with reference diagnoses. Results: Pearson correlations between SCST subtests and corresponding CERAD-K/SNSB-II measures were all significant ( Conclusions: These findings support the SCST's clinical utility; further studies in broader community-based cohorts are warranted to confirm generalizability.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.